editor@aoeds.com
+971 56 754 0322
e-ISSN: 3049-0715
logo

Advances in Obesity, Endocrinology, and Diabetes

📢 Latest Update: New special issue call for papers on "Emerging Technologies in Research" - Submit by March 31, 2026

📢 Latest Update: New special issue call for papers on "Emerging Technologies in Research" - Submit by March 31, 2026

Volume 2, Issue 2 - 2025 (July-December 2025)

Volume 2 Issue 2 Cover

Issue Details:

Volume 2 Issue 2
Published:Jul 21, 2025

Editorial: July-December 2025

Welcome to the 2025 issue of Advances in Obesity, Endocrinology, and Diabetes. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr Lakshmi Nagendra
Editor-in-Chief
Advances in Obesity, Endocrinology, and Diabetes

Articles in This Issue

Showing 10 of 10 articles
Research PaperID: aoeds-00000026

Editorial : Cyclic Cushing syndrome : a challenging diagnosis

IHAB ELTAYEB

CCS (Cyclic Cushing Syndrome), DST (Desmopressin Stimulation Test), ACTH (Adrenocorticotropic Hormone), Inferior Petrosal Sinus Sampling (BIPSS). Cushing's Syndrome (CS). Continuous Glucose Monitoring (CGM). Dexamethasone Suppression Test (DST), Late-Night Salivary Cortisol (LNSC) Cyclic Cushing’s syndrome (CCS) represents a variant of Cushing’s syndrome characterized by alternating episodes of elevated cortisol levels (peaks) and spontaneous intervals of normal or reduced cortisol secretions (troughs) (1). The widely accepted definitions of cyclic Cushing's syndrome are based on two main criteria: the first involves three peaks in cortisol levels that indicate hypercortisolemia, interspersed with two troughs reflecting euocortisolaemia. The second criterion consists of two peaks separated by one trough (1). The duration of these phases can fluctuate, lasting anywhere from several days to 86 days or even extending over years. Cyclic Cushing’s syndrome presents significant challenges within the field of modern endocrinology. It is observed more frequently in women, with a male-to-female ratio of 1:3. In comparison to those with Cushing’s syndrome, patients with cyclic Cushing’s syndrome tend to be older, typically between 50 and 60 years of age, and often have a history of alcohol consumption, averaging 1 to 7 drinks per week( 2).

Cyclic Cushing SyndromeScalp Hair CortisolDesmopressin Stimulation TestInferior Petrosal Sinus SamplingPeaksTroughs
36 views
28 downloads

Contributors:

 IHAB ELTAYEB
Research PaperID: aoeds-00000027

Homozygous Leptin Receptor Mutation Presenting with Severe Obesity, Hypopituitarism, and Type 2 Diabetes: A Case Report

Motaz Azzam, Nandu KS Thalange

Background: Leptin receptor (LEPR) deficiency is a rare autosomal recessive disorder causing severe early-onset obesity, hyperphagia, and multiple endocrine abnormalities. Hypopituitarism is a significant but underrecognized complication of this genetic condition. Case Presentation: We report a 14-year-old girl with homozygous LEPR mutation (c.3132delC; p.Asn1045Thrfs*2) presenting with severe obesity (BMI 62.7 kg/m²), new-onset type 2 diabetes (HbA1c 6.5%), and multiple pituitary hormone deficiencies including hypogonadotropic hypogonadism (undetectable LH/FSH), likely growth hormone deficiency, and central hypothyroidism. Despite advanced bone age indicating she was at near final height, the patient remained prepubertal with significant short stature (7th percentile for height) well below her mid-parental target height of 165 cm (75th percentile). Management included planned therapy with setmelanotide, an MC4R agonist specifically approved for LEPR deficiency, along with pituitary hormone replacement and management of diabetes and dyslipidemia. Conclusions: This case highlights the complex endocrine manifestations of LEPR deficiency beyond obesity, emphasizing the importance of systematic evaluation for hypopituitarism in affected patients. The availability of targeted therapies like setmelanotide represents a paradigm shift in management, offering hope for improved outcomes in this challenging condition. Early recognition and comprehensive endocrine assessment are crucial for optimal patient care and long-term prognosis.

Leptin receptor deficiencyLEPR mutationmonogenic obesityhypopituitarismsetmelanotidepediatric endocrinology
39 views
15 downloads

Contributors:

 Motaz Azzam
,
 Nandu KS Thalange
Research PaperID: aoeds-00000028

Assessment of Podiatric Disorders and Quality of Life in elderly diabetic patients with Diabetic Neuropathy

Aicha GHAACHEM, Hamza ELFEKIH, Aya TRIMECH, Safa AMARA, Wiem SAAFI, Taieb ACH, Imen HALLOUL, Ghada SAAD, Doaa Elwasly, Yosra HASNI

Introduction: Diabetic neuropathy is the most common chronic complication of diabetes. It is a heterogeneous condition including various types of nerve damage. The most prevalent form is symmetrical distal polyneuropathy, which is diagnosed clinically. It involves symmetric and bilateral impairment of nerves, mainly in the distal parts of the lower limbs. Pain associated with diabetic neuropathy is a major health issue and significantly impacts quality of life. The aim of our study is to examine podiatric disorders and quality of life in elderly diabetic patients with and without neuropathy. Patients and Methods: This is a case-control study involving 70 elderly diabetic patients (35 with neuropathy and 35 without), selected through non-probabilistic sampling over a 4-month period. Assessment included the SF-36 quality of life questionnaire, the DN4 score, and a complete clinical podiatric examination in an off-load podiatry assessment. Data entry and statistical analysis were conducted using SPSS version 25. Results: Our analysis revealed that elderly diabetic patients with neuropathy had significantly more comorbidities, trophic disorders, and podiatric issues. Comparison of average SF-36 scores and global quality of life scores between cases and controls showed significant differences across all assessed parameters. The overall score indicated a marked deterioration in both physical and mental health among cases compared to controls, with mean scores of 37.09 and 69.82, respectively (p

Diabetic neuropathypodiatric disordersquality of lifeSF-36
34 views
10 downloads

Contributors:

 Aicha GHAACHEM
,
 Hamza ELFEKIH
,
 Aya TRIMECH
,
 Safa AMARA
,
 Wiem SAAFI
,
 Taieb ACH
,
 Imen HALLOUL
,
 Ghada SAAD
,
 Doaa Elwasly
,
 Yosra HASNI
Research PaperID: aoeds-00000029

Features of Diabetes Mellitus unmasked by COVID-19

Mouna Elleuch, Yesmine Elloumi, Nadia Moussa, Dhouha Ben Salah, Hamdi Frikha, Khouloud Boujelbene, Nadia Charfi, Mouna Mnif, Faten Hadj Kacem, Sami Kammoun

INTRODUCTION: The coronavirus 2019 (COVID-19) pandemic has represented a major global health emergency and It is now recognized as a multisystemic disease, with potential repercussions on various organs. Diabetes mellitus is a common comorbidity associated with COVID-19. Its first-time diagnosis during the course of COVID-19 infection has been frequently reported, often with specific clinical, biological, and prognostic profiles. A better understanding of this association could shed light on the interplay between these two conditions. PATIENTS AND METHODS : This retrospective, descriptive, and analytical study included non-diabetic patients hospitalized for COVID-19 between 2021 and 2022 in the Pulmonology Department of the University Hospital of Sfax. Patients who developed newly diagnosed diabetes during hospitalization were identified and formed the basis of our analysis. RESULTS: New-onset diabetes was identified in 108 patients (12.9%) during hospitalization for COVID-19 with a mean age of 64.4 years and a male-to-female ratio of 1.34. Hypertension was the most common associated comorbidity, reported in 35.2% of cases. Clinically, the most frequent symptoms were dyspnea (60%), fever (55.6%), and cough (52.8%). On physical examination, hypoxia was observed in 65% of patients at admission. Laboratory findings revealed a mean random blood glucose level of 14.8 mmol/L. Chest CT scans showed extensive pulmonary involvement in 58% of cases. Systemic corticosteroids were prescribed in 70.6%. Diabetic ketoacidosis occurred in 4.6% of cases. Nine percent of patients with newly diagnosed diabetes required transfer to an intensive care unit. The mortality rate in this group was 14.7%. At a mean follow-up of 24 months, glycemic status was reassessed. Among reachable patients, 60% remained diabetic. Diarrhea and the severity of radiological lung involvement were identified as independent predictors of new-onset diabetes during COVID-19 infection. CONCLUSION: New-onset diabetes during COVID-19 infection is not uncommon. It is associated with distinct clinical and paraclinical features. Early identification of diabetes in this context is essential for timely and appropriate management to prevent complications.

New-onset diabetesCOVID-19Clinical outcomes
38 views
17 downloads

Contributors:

 Mouna Elleuch
,
 Yesmine Elloumi
,
 Nadia Moussa
,
 Dhouha Ben Salah
,
 Hamdi Frikha
,
 Khouloud Boujelbene
,
 Nadia Charfi
,
 Mouna Mnif
,
 Faten Hadj Kacem
,
 Sami Kammoun
Research PaperID: aoeds-00000030

Prevalence and Risk factors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Patients with Type 2 Diabetes

Yesmine Elloumi, Mouna Elleuch, Wissal Abbes, Khouloud Boujelben, Faten Hadj Kacem, Nadia Charfi, Mouna Mnif, Dhoha Ben Salah, Nabila Rekik Mejdoub

Background: The coexistence of type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) accelerates the progression of cardiovascular and metabolic disorders. To mitigate the medical and economic burden associated with these comorbidities, identifying their risk factors is essential. Aim: to assess the prevalence of MASLD and identify its associated risk factors in T2D patients in Tunisia. Methods: This descriptive and analytical study included 202 T2D patients followed over a 12-year period at the Endocrinology Department in Sfax, Tunisia. Patients were divided into two groups: 101 patients with confirmed MASLD (G1) and 101 patients without MASLD (G2). Results: The prevalence of MASLD was 17.03%. A family history of autoimmunity was significantly associated with MASLD. Glycemic control indicators, including HbA1C levels (p=0.943) and blood glucose levels (p=0.627), did not differ between groups. Insulin therapy was significantly less common in G1 (p=0.027). Abdominal obesity and elevated triglyceride levels were strongly associated with MASLD. Additionally, carbohydrate intake was higher in G1 compared to G2 (p=0.041). Multivariate analysis identified non-HDL cholesterol as the most significant independent risk factor for MASLD (odds ratio [OR]: 4.07 × 10⁵), followed by uric acid levels (OR: 1.03, p=0.024) in a 95% confidence interval of [1.004–1.058]. Conclusion: The findings reveal a notable prevalence of MASLD among T2D patients in Tunisia, with non-HDL cholesterol, uric acid levels, abdominal obesity, and dietary patterns emerging as key contributors. These results emphasize the need for targeted screening and management strategies of MASLD.

Type 2 diabetesMetabolic Dysfunction-Associated Steatotic Liver DiseaseRisk factorsMetabolic disorders
39 views
11 downloads

Contributors:

 Yesmine Elloumi
,
 Mouna Elleuch
,
 Wissal Abbes
,
 Khouloud Boujelben
,
 Faten Hadj Kacem
,
 Nadia Charfi
,
 Mouna Mnif
,
 Dhoha Ben Salah
,
 Nabila Rekik Mejdoub
Research PaperID: aoeds-00000031

Choroidal calcification revealing a primary hyperparathyroidism: A case report.

Ben Nacef Ibtissem, Faten Cherchir, Mekni Sabrine, Laamouri Rihab, Essayeh Saousen, Rojbi Imen, Khiari Karima

Choroidal calcification is an uncommon benign lesion occurring in predominantly elderly. This condition is ordinarily idiopathic. However, it can be caused by phosphocalcic metabolism disorders. We report the case of a 72-year-old woman followed-up in the ophthalmology department for proliferative diabetic retinopathy who was found to have a bilateral yellowish lesion in the fundus during a routine eye examination corresponding to a choroidal calcification. Metabolic analyses led to the diagnosis of primary hyperparathyroidism. Choroidal calcifications warrant a systemic evaluation to identify a potential underlying disease.

Choroidal calcificationbilateral yellowish lesionphosphocalcic metabolism disordershyperparathyroidism
36 views
11 downloads

Contributors:

 Ben Nacef Ibtissem
,
 Faten Cherchir
,
 Mekni Sabrine
,
 Laamouri Rihab
,
 Essayeh Saousen
,
 Rojbi Imen
,
 Khiari Karima
Research PaperID: aoeds-00000032

Title: Diabetic foot in type 1 diabetes mellitus

Hajer MARZOUK, Hamza ELFEKIH, Farah LOUHICHI, Safa AMARA, Wiem SAAFI, Taieb ACH, Imen HALLOUL, Ghada SAAD, Wided DEBBABI, Yosra HASNI

Background : Diabetes mellitus is a public health problem. Diabetic foot is one of its major complications and is secondary to neuropathy, arteriopathy, infectious and mechanical foot involvement. It is a major cause of lower limb amputation and thus of motor disability. Material and methods We propose a descriptive study of the main anomalies found in the examination of thefeet in 40 patients with type 1 diabetes. Results: The median age of our population was 34.5 years. The average duration of diabetes was 25.35 years. 15% of people have neuropathic pain, and about one third describe the pain as severe. Hallux valgus and claw toes were observed in 35% of patients and a Charcot foot was found in 2 patients. 10% of subjects already had stage 4 arterial disease and 10% had intermittent claudications. The results of the care of 3 patients through telemedicine are encouraging. Management was early and further damage was prevented. Conclusion: Foot involvement in diabetes mellitus is common and often severe. Early intervention, via telemedicine, could improve outcomes.

diabetic footneuropathyarteriopathyCharcot foottelemedecine
35 views
24 downloads

Contributors:

 Hajer MARZOUK
,
 Hamza ELFEKIH
,
 Farah LOUHICHI
,
 Safa AMARA
,
 Wiem SAAFI
,
 Taieb ACH
,
 Imen HALLOUL
,
 Ghada SAAD
,
 Wided DEBBABI
,
 Yosra HASNI
Research PaperID: aoeds-00000033

Laparoscopic Management of Idiopathic Abdominal Cocoon in a 32-Year-Old Male: A Rare Case Report

Haitham Sawalmeh, Doaa Elwasly, Vandana Tak

Background: Abdominal cocoon is a rare cause of intestinal obstruction with fewer than 200 cases reported worldwide [11]. We present a case managed successfully through laparoscopy. Case Presentation: A 32-year-old male presented with acute abdominal pain, nausea, and distension. CT abdomen revealed dilated small bowel loops and clustered appearance suggestive of small bowel obstruction. Laparoscopy confirmed idiopathic abdominal cocoon, and complete excision of the fibrous sac was performed. Conclusion: Laparoscopy is effective for both the diagnosis and treatment of abdominal cocoon, offering significant advantages over open surgery.

Abdominal cocoonSclerosing encapsulating peritonitisLaparoscopyIntestinal obstruction
30 views
13 downloads

Contributors:

 Haitham Sawalmeh
,
 Doaa Elwasly
,
 Vandana Tak
Research PaperID: aoeds-00000034

Postoperative Hungry Bone Syndrome Following VATS Resection of Ectopic Mediastinal Parathyroid Adenoma: A Case Report

Dr Khaldoon Abo Dakka, Dr Anil Kumar Pura Narayanaswamy, Dr Syed Zafar, Dr Omar Fawzi Lootah

Hungry bone syndrome (HBS) is characterized by persistent hypocalcemia and hypophosphatemia as a result of extensive remineralization following parathyroidectomy. It is a known but uncommon complication of parathyroid surgery, seen in 13–30% of cases. In this article, we report the case of a 36-year-old woman with increased thirst and polyuria as the first manifestation of primary hyperparathyroidism caused by an ectopic parathyroid adenoma located in the anterior mediastinum. After a single-port Thoracoscopic parathyroidectomy, the patient presented clinical signs of hypocalcemia consistent with hungry bone syndrome. This report highlights the diagnostic approach, surgical management, and postoperative care, emphasizing the importance of early recognition and intervention.

Hungry bone syndromeectopic parathyroid adenomaprimary hyperparathyroidismVATS
31 views
15 downloads

Contributors:

 Dr Khaldoon Abo Dakka
,
 Dr Anil Kumar Pura Narayanaswamy
,
 Dr Syed Zafar
,
 Dr Omar Fawzi Lootah
Research PaperID: aoeds-00000035

Vascular Calcification: Understanding the Pathophysiology and Exploring Preventive Strategies- A Narrative Review

Maha A. Mohamed, Yalda Rahmani, Tooba Durrani, Shiza Ali, Hafsa Chhapra, Mohamed Hussein

Background: Cardiovascular calcification is defined as the deposition of calcium in vascular tissues. It represents a key aspect of cardiovascular disease pathology, and a serious medical problem associated with high morbidity and mortality. Main body: This review studies the intricate mechanisms underlying vascular calcification to elucidate its multifactorial etiology. Furthermore, it examines the contributory roles of traditional cardiovascular risk factors, genetic predispositions, and molecular pathways that influence the beginning and development of calcification in arterial walls. It also investigates emerging strategies for preventing and mitigating vascular calcification. Novel interventions, including pharmacological agents, lifestyle modifications, and targeted therapies, are examined in the context of their potential to counteract the calcification process. Conclusions: The findings hold promise for developing personalized preventive strategies that reduce the burden of cardiovascular disease worldwide.

Vascular CalcificationCardiovascular DiseaseMolecular PathwaysPathophysiologyPrevention
39 views
15 downloads

Contributors:

 Maha A. Mohamed
,
 Yalda Rahmani
,
 Tooba Durrani
,
 Shiza Ali
,
 Hafsa Chhapra
,
 Mohamed Hussein
Whatsapp